parenchymal
CONCLUSIONS: Except for patients with       brittle glycemic control, manifest hypoglycemic unawareness, renal parenchymal       disease, or documented intolerance, beta blockers should no longer be considered        routinely contraindicated in the presence of diabetes.
CONCLUSIONS: Except for patients with       brittle glycemic control, manifest hypoglycemic unawareness,  @OBJECT$  @SUBJECT$  @PREDICAT$ , or documented intolerance, beta blockers should no longer be considered        routinely contraindicated in the presence of diabetes.